Yunnan Baiyao
Yunnan Baiyao Group Co., Ltd., commonly known as Yunnan Baiyao, is a leading Chinese pharmaceutical company headquartered in Kunming, Yunnan Province, China. Established in 1902, the company has a rich history marked by significant milestones in traditional Chinese medicine and modern healthcare. Specialising in the production of herbal medicines, Yunnan Baiyao is renowned for its unique formulations, particularly its haemostatic products that are widely used in both clinical and home settings. The company has carved a prominent position in the pharmaceutical industry, recognised for its commitment to quality and innovation. With a strong presence in both domestic and international markets, Yunnan Baiyao continues to expand its product range, which includes traditional remedies and modern healthcare solutions, solidifying its reputation as a pioneer in the integration of traditional and contemporary medicine.
DitchCarbon Score
How does Yunnan Baiyao's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yunnan Baiyao's score of 22 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Yunnan Baiyao's reported carbon emissions
In 2023, Yunnan Baiyao reported total carbon emissions of approximately 29,349,710 kg CO2e, which includes 28,983,100 kg CO2e from Scope 1 emissions and 365,450 kg CO2e from Scope 2 emissions. The company has not disclosed any data related to Scope 3 emissions. Currently, Yunnan Baiyao has not set any specific reduction targets or climate pledges, indicating a lack of formal commitments towards reducing their carbon footprint. This absence of defined climate initiatives places the company in a broader industry context where many organisations are increasingly prioritising sustainability and emissions reduction. As Yunnan Baiyao continues to operate within the pharmaceutical sector, it may benefit from adopting industry-standard climate strategies to enhance its environmental performance and align with global sustainability trends.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 28,983,100 |
| Scope 2 | 365,450 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yunnan Baiyao is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
